Evidence map›Paper›PMID 41329809›Full record

ReviewPediatric annals2025

Pediatric Cancer Survivorship: A Review.

Erika Foerst, Vincent Cendan, Bhumika Gandhi, Lindsay F Schwartz, Tara K Suntum

Abstract readReview
In one paragraph

Review in Pediatric annals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erika FoerstMedStar Georgetown University Hospital, Washington, DC.
Vincent CendanMedStar Georgetown University Hospital, Washington, DC.
Bhumika GandhiMedStar Georgetown University Hospital, Washington, DC.
Lindsay F SchwartzAnn & Robert H. Lurie Children's Hospital of Chicago, and Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Tara K SuntumMedStar Georgetown University Hospital, Washington, DC.

Funding

Developing an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6M
NCI NIH HHS K12 CA139160NCI NIH HHS L40 CA274778
6 · The paper itself

Abstract

Following cancer treatment, childhood cancer survivors (CCS) are at risk for adverse physical, psychosocial, functional, and behavioral long-term health outcomes, known as "late effects." Risk for late effects is individualized based on the survivor's treatment exposures and can occur years or decades after treatment. Lifelong survivorship care is needed for screening, prevention, and treatment of late effects. Studies have shown that survivor-focused care declines over time; however, survivors remain engaged with regular medical care. It is important for primary care health care professionals to be aware of resources when caring for this unique population. Multiple domestic and international guidelines are available to provide recommended evaluations for cancer survivors based on their treatment exposures. This review highlights important topics relevant for health care professionals caring for CCS, including organ system-specific late effects, psychosocial care, subsequent neoplasms, immunizations, and transition of medical care.

Indexed as

Cancer SurvivorsContinuity of Patient CareNeoplasmsSurvivorshipChildHumans

Identifiers

PMID41329809
PMCPMC13133806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.